Sort
39,280 grants matching “leukemia”
EM Cryst. Core
$310,289Mark Jay Yeager · University Of Utah · P50 · FY2016 · GM
Immunologic targets in Myeloid Leukemia
$310,286Richard J Jones · Johns Hopkins University · R01 · FY2013 · CA
Translational Investigation of KRas & NF1 in Myeloid Leukemia
$310,254Kevin M Shannon · University Of California, San Francisco · R37 · FY2009 · CA
(PQB3) CD4 T cell response to BCR-ABL-positive Leukemia
$310,254Michael A. Farrar · University Of Minnesota · R01 · FY2014 · CA
Translational Investigation of KRas & NF1 in Myeloid Leukemia
$310,254Kevin M Shannon · University Of California, San Francisco · R37 · FY2010 · CA
Recombinant AAV Gene Therapy Vector Recombination, Integration, and Genotoxicity
$310,235Douglas M McCarty · Research Inst Nationwide Children'S Hosp · R01 · FY2007 · AI
Novel selective small-molecule inhibitors of Mcl-1 protein
$310,232Zaneta Nikolovska-Coleska · University Of Michigan At Ann Arbor · R01 · FY2011 · CA
Assaying Tyrosine Kinase Activity: A New Paradigm
$310,218Christopher E Sims · Univ Of North Carolina Chapel Hill · R33 · FY2007 · CA
Novel lysine deacetylase 6 Hsp domain inhibitors against AML
$310,213Chung-Jen James Chou · Medical University Of South Carolina · R01 · FY2016 · CA
Notch-1 and IGF-1 crosstalk: new therapeutic strategies for NSCLC
$310,213Maurizio Bocchetta · Loyola University Chicago · R01 · FY2010 · CA
Novel lysine deacetylase 6 Hsp domain inhibitors against AML
$310,213Chung-Jen James Chou · Medical University Of South Carolina · R01 · FY2017 · CA
Targeting the Pim 1 Protein Kinase to Overcome Resistance to AKT Inhibitors
$310,213Andrew S Kraft · Medical University Of South Carolina · R01 · FY2013 · CA
Novel lysine deacetylase 6 Hsp domain inhibitors against AML
$310,213Chung-Jen James Chou · Medical University Of South Carolina · R01 · FY2015 · CA
Novel selective small-molecule inhibitors of Mcl-1 protein
$310,210Zaneta Nikolovska-Coleska · University Of Michigan At Ann Arbor · R01 · FY2012 · CA
Quantitative HOX Expression as Prognostic Marker in AML
$310,193University Of Colorado Denver · R33 · FY2004 · CA
Characterization of PBIP1, a novel polo-box-binding protein at the kinetochores
$310,192Kyung W Lee · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Signal Transduction Pathways in CD30-positive Lymphomas
$310,192Colin S. Duckett · University Of Michigan At Ann Arbor · R01 · FY2012 · CA
Biofunctional Polymers for Intracellular Drug Delivery
$310,192Patrick S. Stayton · University Of Washington · R01 · FY2009 · EB
Project 4: Enhancing the Efficacy of Chimeric Antigen Receptor Therapy for B-ALL and DLBCL
$310,192Crystal Mackall · Stanford University · P01 · FY2022 · CA
Cancer Genetics
$310,178Max S. Wicha · University Of Michigan At Ann Arbor · P30 · FY2015 · CA
SOUTHWEST ONCOLOGY GROUP
$310,163Wayne State University · U10 · FY2000 · CA
Mechanism(s) of TAL1- and NOTCH1-mediated Leukemogenesis
$310,160Michelle Alice Kelliher · Univ Of Massachusetts Med Sch Worcester · R01 · FY2014 · CA
Role of the STK Receptor in Erythropoiesis
$310,147Pamela A Hankey · Pennsylvania State University, The · R01 · FY2006 · HL
The Role of LIF, a Novel Negative Regulator of p53, in Colorectal Cancer
$310,130Wenwei Hu · Rbhs -Cancer Institute Of New Jersey · R01 · FY2013 · CA
Chronic Myelogenous Leukemia and Bcr-Abl Substrates
$310,124Brian J Druker · Oregon Health & Science University · R01 · FY2007 · CA